Reagentia en instrumenten voor immunologie, celbiologie en moleculaire biologie.
Inloggen
Wachtwoord vergeten?
Open een account
fr
en
es
de
it
pt
nl
0
0
Naar winkelmandje
Catalogus
Onderzoeksgebieden
Diagnostiek
Diensten op maat
CRO services
Technische middelen
Promoties
Contact
Reagentia en instrumenten voor immunologie, celbiologie en moleculaire biologie.
Resultaat van uw zoeken : 19 product gevonden
Verfijn uw zoekopdracht :
RUO
CE / IVD
Conjugate (1)
Unconjugated
9
Class (2)
Inhibitor/Antagonist/Agonist
14
Other products
5
BRENG DE FILTERS AAN
INITIALISEREN
DEEL DEZE ZOEKOPDRACHT
GEKOPIEERD
10
20
50
100
200
500
Referentie
Beschrijving
Cond.
Price Bef. VAT
L2620-30μL
Anti-Neurodegenerative Disease Compound Library
30μL
L2620-1mg
Anti-Neurodegenerative Disease Compound Library
1mg
L2620-100μL
Anti-Neurodegenerative Disease Compound Library
100μL
L2620-50μL
Anti-Neurodegenerative Disease Compound Library
50μL
L2620-250μL
Anti-Neurodegenerative Disease Compound Library
250μL
orb1910676-250mg
COH1 is a ribonucleotide reductase (RR) inhibitor. COH1 can be used in research into cancer, mitochondrial diseases, and neurodegenerative diseases. [[20217-22-5]]
250mg
orb1910676-100mg
COH1 is a ribonucleotide reductase (RR) inhibitor. COH1 can be used in research into cancer, mitochondrial diseases, and neurodegenerative diseases. [[20217-22-5]]
100mg
orb1910676-1g
COH1 is a ribonucleotide reductase (RR) inhibitor. COH1 can be used in research into cancer, mitochondrial diseases, and neurodegenerative diseases. [[20217-22-5]]
1g
orb1910497-250mg
Pifithrin-β (PFT β hydrobromide; Cyclic Pifithrin-α hydrobromide) is a potent inhibitor of p53 with an IC50 of 23 μM and is regarded as a lead compound for cancer and neurodegenerative disease therapy. [[60477-34-1]]
250mg
orb1910497-1g
Pifithrin-β (PFT β hydrobromide; Cyclic Pifithrin-α hydrobromide) is a potent inhibitor of p53 with an IC50 of 23 μM and is regarded as a lead compound for cancer and neurodegenerative disease therapy. [[60477-34-1]]
1g
orb1910497-100mg
Pifithrin-β (PFT β hydrobromide; Cyclic Pifithrin-α hydrobromide) is a potent inhibitor of p53 with an IC50 of 23 μM and is regarded as a lead compound for cancer and neurodegenerative disease therapy. [[60477-34-1]]
100mg
orb1910646-1g
ABX-002 is a novel CNS-penetrant TR-B agonist prodrug with potential for treatment of demyelinating disorders as well as other neuroinflammatory and/or neurodegenerative diseases.
1g
orb1910646-250mg
ABX-002 is a novel CNS-penetrant TR-B agonist prodrug with potential for treatment of demyelinating disorders as well as other neuroinflammatory and/or neurodegenerative diseases.
250mg
orb1910646-100mg
ABX-002 is a novel CNS-penetrant TR-B agonist prodrug with potential for treatment of demyelinating disorders as well as other neuroinflammatory and/or neurodegenerative diseases.
100mg
HY-L086-100ul
Neurodegenerative Disease-related Compound Library
100ul
HY-L086-250ul
Neurodegenerative Disease-related Compound Library
250ul
HY-L086-30ul
Neurodegenerative Disease-related Compound Library
30ul
HY-L086-2x100ul
Neurodegenerative Disease-related Compound Library
2x100ul
HY-L086-50ul
Neurodegenerative Disease-related Compound Library
50ul
‹
›
